Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

Hematologic Oncology Update

English - October 12, 2023 18:31 - 46 minutes - 37.3 MB - ★★★★★ - 67 ratings
Science Health & Fitness Medicine cancer hematologic oncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Next Episode: Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences

Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.